Emily Friedland

VP, Clinical Research @ DCN Dx arrow icon

Known information

  • Authored an article titled 'New Rules, New Approaches: Understanding the FDA’s IVD Reclassification Impact'

About DCN Dx

DCN Dx specializes in contract assay development and manufacturing of in vitro diagnostic devices, offering a comprehensive range of services from product design to market evaluation, compliant with EN 13485 and ISO 9001 standards.

report flag Report inaccurate information

People similar to Emily Friedland

Keith Kopitzke

Principal Engineer @ DCN Dx

Patrick Vaughan

Chief Operating Officer @ DCN Dx

Mitzi Rettinger

Chief Revenue Officer @ DCN Dx

Unlock exclusive insights

Sign up to reveal more information.

loader Sign up for free